Dermatology

6/20/19 → 6/30/24

Project: Research project

A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY ANDEFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA

6/17/19 → 6/30/24

Project: Research project

Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma

Maher, I.

CASTLE BIOSCIENCES, INC.

2/6/19 → 2/29/24

Project: Research project

Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), AlopeciaUniversalis (AU) and Alopecia Totalis (AT)

ACLARIS THERAPEUTICS, INC

1/4/19 → 1/31/24

Project: Research project

Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficay of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma

SOLIGENIX INC

11/27/18 → 5/6/22

Project: Research project

A Phase 2B/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss

10/9/18 → 10/30/23

Project: Research project

Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-monthOpenlabelFollow-up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa

Farah, R. S. & Hordinsky, M. K.

AMRYT RESEARCH, LTD

8/30/18 → 8/30/23

Project: Research project

A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study ofPatidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal CellCarcinomas (BCCs) in Subjects with Basal Cell Nevus

Maher, I.

PELLEPHARM, INC.

8/27/18 → 8/31/23

Project: Research project

WEN Shampoo Study

CHAZ DEAN, INC.

8/27/18 → 10/31/21

Project: Research project

A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata

Eli Lilly and Company

8/6/18 → 8/30/23

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis

ACLARIS THERAPEUTICS, INC

6/15/18 → 6/30/22

Project: Research project

An Open Label Extension Study to Assess the Long Term Safety and Efficacy of Dupilumab in Patients > 6months to < 18 years of age with Atopic Dermatitis

Maguiness, S.

Regeneron Pharmaceuticals, Inc.

11/1/17 → 11/30/22

Project: Research project

A double-blind, randomized, vehicle controlled, crossove

ELORAC INC

10/1/17 → 2/20/21

Project: Research project

A Randomized, Double-blind, Vehicle-controlled

ACLARIS THERAPEUTICS, INC

8/1/17 → 8/30/21

Project: Research project

An International, Multicenter, Randomized, Double-Blind,

MEDPACE, INC.

8/1/17 → 8/30/21

Project: Research project

A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,

Regeneron Pharmaceuticals, Inc.

6/21/17 → 1/30/22

Project: Research project

A Phase 2/3 Study Investigation the Phamacokinetics, Saf

Maguiness, S.

2/1/17 → 2/28/23

Project: Research project

Multicenter, Randomized, Double-Blind Placebo-Controlled

Allergan, Inc.

3/1/16 → 3/30/21

Project: Research project

Mechanism of immune modulation by DPCP in alopecia

NATIONAL ALOPECIA AREATA FOUNDATION

1/1/16 → 12/31/21

Project: Research project

An Open-Label (Part A) and a Double-Blind, Randomized, P

Incyte Corporation

8/1/15 → 8/30/20

Project: Research project

A Prospective Observational Study of Treatment Patterns

Bohjanen, K. A. & Lee, P. K.

Genentech Inc.

6/3/13 → 6/30/20

Project: Research project

A PROSPECTIVE OBSERVATIONAL STUDY OF TREATMENT PATTERNS

Bohjanen, K. A. & Lee, P. K.

Genentech Inc.

6/3/13 → 6/30/20

Project: Research project

Phase IV Randomized Study of Two Dose Levels of Targetin

EISAI MEDICAL RESEARCH INC.

3/18/10 → 12/31/20

Project: Research project

A Randomized, Double-Blind Clinical Trial to Evaluate th

Lexington International, LLC

11/17/09 → 12/31/20

Project: Research project

Finished

A Multi-center Study to Evaluate the Pharmacokinetics ofDiacerein and Rhein and the Safety of Diacerein after MaximumUse, Topical Administration of CCP-020 (Diacerein 1%ointment) to Patients with Epidermolysis Bullosa (EB)

CASTLE CREEK PHARMACEUTICALS, LLC

1/21/19 → 7/31/19

Project: Research project

An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)

CASTLE CREEK PHARMACEUTICALS, LLC

1/1/19 → 7/31/19

Project: Research project

Intergrated Behavioral Healthcare in Dermatology: A C-Located Care Pilot Study.

Hordinsky, M. K. & Berge, J. M.

University of Wisconsin-Stout

10/1/18 → 9/30/19

Project: Research project

Cutaneous T-Cell Lymphoma study

Goyal-O'Leary, A.

AMERICAN SOCIETY OF HEMATOLOGY

7/1/18 → 9/30/19

Project: Research project

Epidermolysis Bullosa Clinical Characterization and Outc

Hook, K. P. & Boull, C. L.

EPIDERMOLYSIS BULLOSA MED RESEARCH FOUND

8/24/17 → 6/30/18

Project: Research project

Characteristics of patients with mycosis fungoides/Sezar

Goyal-O'Leary, A.

AMERICAN SOCIETY OF HEMATOLOGY

7/1/17 → 6/30/18

Project: Research project

Severity and Culture Status in Epidermolysis Bullosa wit

PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE

3/1/17 → 12/31/19

Project: Research project

Program for Innovative Continuing Medical Education in D

Hurliman, E. & Reich, H. C.

AMERICAN ACADEMY OF DERMATOLOGY

1/1/17 → 12/31/18

Project: Research project

Allogeneic skin grafting in the treatment of chronic

Shih, T. L. & Miller, D. D.

WOMEN'S DERMATOLOGIC SOCIETY

7/15/16 → 7/14/19

Project: Research project

Cutaneous Findings in Fanconi Anemia and Patient Percept

Boull, C. L., Hook, K. P., Maguiness, S. & Polcari, I. C.

PEDIATRIC DERMATOLOGY RESEARCH ALLIANCE

7/1/16 → 12/31/17

Project: Research project

Cannabinoid-based therapy and approaches to quantify pai

Gupta, K., Bagchi, A., Connett, J. E., Datta, Y. H., Ericson, M. E., He, B., Honda, C. N., Simone, D. A. & Ugurbil, K.

National Institutes of Health

6/1/16 → 5/31/19

Project: Research project

An Open Label Multi-Center Extension Study to Evaluate

SCIODERM, INC.

4/22/16 → 4/30/20

Project: Research project

A Phase 3, Multi-center, Randomized, Double-Blind

THE SOCIETY FOR PEDIATRIC DERMATOLOGY

SCIODERM, INC.

4/20/16 → 4/30/20

Project: Research project

Intralesional cidofovir for the treatment of recalcitran

Polcari, I. C.

10/22/15 → 4/21/17

Project: Research project

Skin Dendritic Cells and Humoral Immunity

Jenkins, M. & Hordinsky, M. K.

University of Pittsburgh

9/1/15 → 3/31/20

Project: Research project

Epidermolysis Bullosa Clinical Characterization

EB RESEARCH PARTNERSHIP, INC.

8/5/15 → 6/30/17

Project: Research project

Skin Dendritic Cells and Humoral Immunity

Kaplan, D. H., Igyarto, B. Z. & Jenkins, M.

NIH NIAMS NATL INST OF ARTHRIT

4/6/15 → 8/31/15

Project: Research project

A 2-Year, Open-Label, Safety Extension Study of Gevokizu

AMERICAN SKIN ASSOCIATION

XOMA Corporation

1/1/15 → 12/31/18

Project: Research project

Keratinocytes Control Homeostatic and Inflammation-induc

Shaik, J.

1/1/15 → 1/1/15

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled Study of

XOMA Corporation

1/1/15 → 12/31/18

Project: Research project

A Randomized, Double-Blind, Double-Dummy

AMERICAN ASSOCIATION OF IMMUNOLOGISTS

Genentech Inc.

12/17/14 → 12/16/18

Project: Research project

Langerhans cell and CD103+dDC in humoral response

Kaplan, D. H. & Yao, C.

10/1/14 → 9/30/15

Project: Research project

EPIDERMOLYSIS BULLOSA CLINICAL CHARACTERIZATION AND OUTC